Ivermectin Decreases Mortality

If you are looking for Ivermectin Treatment Protocols, you can find them right here.

Story at-a-glance

• While ivermectin has been widely vilified as either useless, dangerous or both, studies have repeatedly demonstrated its usefulness against COVID-19
• A study published in the March 2022 issue of the International Journal of Infectious Diseases again found that treatment with ivermectin reduced mortality in COVID-19 patients to a greater degree than remdesivir
• Another recent study found ivermectin was the most effective drug treatment against the Omicron variant out of 10 drugs, including nirmatrelvir (Paxlovid), which was granted emergency use authorization against COVID in December 2021
• Remdesivir costs between $2,340 and $3,120, and nirmatrelvir (Paxlovid), costs $529 per treatment, while the average treatment cost for ivermectin is $58
• In 2021, Dr. Andrew Hill published a meta-analysis on ivermectin against COVID. While he’d expressed great enthusiasm about the data and had agreed to work to get ivermectin approved as soon as possible, the conclusion of his paper was that more large-scale studies were needed before regulators could take action. It appears one or more people pressured him to change the conclusion of his paper, and some believe at least one culprit may now have been identified

While ivermectin has been widely vilified as either useless, dangerous or both, studies have repeatedly demonstrated its usefulness against COVID-19. Most recently, a study¹ published in the March 2022 issue of the International Journal of Infectious Diseases again found that treatment with ivermectin reduced mortality in COVID-19 patients — and to a greater degree than remdesivir.

In the video above, nursing educator John Campbell, Ph.D., reviews the findings of this paper. Importantly, the researchers compared the use of ivermectin against the use of remdesivir, which is one of the few drugs recommended for use against COVID in the U.S.

To compare outcomes between the two treatments, they analyzed data from a network of 44 health care organizations with 68 million patients. Patients aged 18 and over with a recorded COVID-19 infection between January 1, 2020, and July 11, 2021, were included in the analysis. Patients who received only remdesivir but not ivermectin were compared against those who received ivermectin but not remdesivir.

After controlling for a variety of confounding factors, including but not limited to comorbidities, other treatments that might affect COVID-19 survival, age, gender, ethnicity, nicotine use, diabetes, obesity and ventilator use, they concluded that treatment with ivermectin reduced mortality to a greater degree than remdesivir.

As noted by Campbell, remdesivir is an extremely expensive drug, costing between $2,340 and $3,120 depending on your insurance.² Ivermectin, meanwhile, costs between $48³ and $95⁴ for 20 pills depending on your location. The average cost is said to be about $58 per treatment.⁵

Ivermectin Outperforms Other Drug Options

Another recent investigation by Cornell University, posted on the University’s preprint server⁶ January 20, 2022, found ivermectin outperformed no less than 10 other drugs. Here, the researchers used a computational analysis to look at the Omicron variant, which has demonstrated a lower clinical presentation and lower hospital admission rates.

After having retrieved the complete genome sequence and collecting 30 variants from the database, the researchers analyzed 10 drugs against the virus, including ivermectin, nirmatrelvir, ritonavir, lopinavir and boceprevir. While all of the 10 drugs had some degree of effectiveness against the virus, ivermectin was the most effective against the Omicron variant.

READ THE REST HERE

A PDF version of the story can be found here from Mercola.